FDA Pushes Back on Opdivo

Wednesday, August 12, 2015

Source: The Wall Street Journal

The Food and Drug Administration pushed back the decision date on an expanded use of Bristol-Myers Squibb Co.’s cancer drug Opdivo to Nov. 27, Bristol-Myers said Wednesday.

View All News »